Liver preservation: Is there anything new yet?

Current Opinion in Organ Transplantation

Volumn 13, Issue 2, 2008, Pages 148-154

  Guarrera, James V ^a,b   Karim, Niaz A ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Ischemia reperfusion; Liver transplantation; Machine perfusion; Organ preservation; Preservation solution

Indexed keywords

3 [2 [(2 TERT BUTYLPHENYLAMINOOXALYL)AMINO]PROPIONYLAMINO] 4 OXO 5 (2,3,5,6 TETRAFLUOROPHENOXY)PENTANOIC ACID; ANTIOXIDANT; ARGINYLGLYCYLASPARTIC ACID; CELSIOR; HEAT SHOCK PROTEIN; HTK SOLUTION; IGL 1; MATRIX METALLOPROTEINASE INHIBITOR; NITRIC OXIDE; PENTOXIFYLLINE; POLYSOL; PRESERVATION SOLUTION; RINGER LACTATE SOLUTION; TRIMETAZIDINE; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION; VASOSOL;

CLINICAL TRIAL; EXTRACORPOREAL OXYGENATION; HEART DEATH; HUMAN; LIVER ISCHEMIA; LIVER PRESERVATION; LIVER TRANSPLANTATION; LIVING DONOR; MACHINE; REPERFUSION; REVIEW;

CLINICAL TRIALS AS TOPIC; HUMANS; LIVER; LIVER TRANSPLANTATION; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PERFUSION;

EID: 40649084884     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3282f63930     Document Type: Review

References (52)